BRIANNA POLKA: Open Payments
NPI 1124801667 · BUTLER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$477 in 26 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $149 · 2025 $477
Food & beverage: $461Education: $16
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $88 |
| Novo Nordisk Inc | 4 | $85 |
| GlaxoSmithKline, LLC. | 2 | $47 |
| ABBVIE INC. | 2 | $42 |
| PFIZER INC. | 2 | $38 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $35 |
| Amgen Inc. | 2 | $35 |
| Neurocrine BioSciences, Inc. | 1 | $27 |
| Phathom Pharmaceuticals, Inc. | 2 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
Products named: MOUNJARO, Ozempic, TRELEGY ELLIPTA, XIFAXAN, JARDIANCE, INGREZZA, VOQUEZNA, CREON.
Industry payments across PA — which companies pay providers there.
